Kensey Nash's smaller puncture closure device gains CE-Mark:
This article was originally published in Clinica
Executive Summary
Kensey Nash has CE-marked a smaller version of its Angio-Seal puncture closure device. The new 6F device will allow the company to address the largest segment of the estimated $1 billion puncture closure market following cardiovascular catheterisation procedures. Approximately 70% of the 6.5 million cardiovascular procedures performed each year are carried out through a 6F or smaller puncture in the femoral artery, said the Exton Pennsylvania-based company.